Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 27578-60-5 Chemical Structure| 27578-60-5
Chemical Structure| 27578-60-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Álvaro Peña ; Juan Heredero ; Beatriz Blandín ; Elena Mata ; Diego De Miguel ; Alfonso Toro , et al.

Abstract: Ionizable lipids are an essential component of lipid nanoparticles (LNPs) for an efficient mRNA delivery. However, optimizing their chemical structures for high protein expression, efficient endosomal escape, and selective organ targeting remains challenging due to complex structure-activity relationships and multistep synthesis. In this study, we introduce a rapid, high-throughput platform for screening ionizable lipids using a two-step, scalable synthesis involving a one-pot 3-component click-like reaction. This method, herein known as the STAAR approach, standing for Sequential Thiolactone Amine Acrylate Reaction, allowed for the combinatorial synthesis and in vivo screening of 91 novel lipids, followed by a structure-activity study. This led to the development of CP-LC-0729, an ionizable lipid that significantly surpasses the benchmark in protein expression while showing no in vivo toxicity. Additionally, the STAAR lipid platform was further validated by incorporating a one-step strategy to yield a permanently cationic lipid which was tested following a fifth-lipid formulation strategy. The in vivo results showed a highly selective lung delivery with a 32-fold increase in protein expression, outperforming current endogenous targeting strategies. All these findings underscore the potential of lipid CP-LC-0729 and the STAAR lipid platform in advancing the efficiency and specificity of mRNA delivery systems, while also advancing the development of new ionizable lipids.

Keywords: lipid nanoparticle ; ionizable lipid ; drug delivery ; lipids ; extrahepatic ; lung targeting ; mRNA therapeutics

Purchased from AmBeed: ;

Li, Bowen ; Manan, Rajith Singh ; Liang, Shun-Qing ; Gordon, Akiva ; Jiang, Allen ; Varley, Andrew , et al.

Abstract: The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for mRNA and CRISPR-Cas9 gene editors. Lead lipid nanoparticles are amenable for repeated intratracheal dosing and could achieve efficient gene editing in lung epithelium, providing avenues for gene therapy of congenital lung diseases.

Alternative Products

Product Details of 1-(2-Aminoethyl)piperidine

CAS No. :27578-60-5
Formula : C7H16N2
M.W : 128.22
SMILES Code : NCCN1CCCCC1
MDL No. :MFCD00006516
InChI Key :CJNRGSHEMCMUOE-UHFFFAOYSA-N
Pubchem ID :33944

Safety of 1-(2-Aminoethyl)piperidine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H226-H314
Precautionary Statements:P280-P305+P351+P338-P310
Class:8(3)
UN#:2734
Packing Group:

Application In Synthesis of 1-(2-Aminoethyl)piperidine

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 27578-60-5 ]

[ 27578-60-5 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 110-89-4 ]
  • [ 926-39-6 ]
  • [ 27578-60-5 ]
  • 2
  • [ 27578-60-5 ]
  • [ 42926-52-3 ]
  • 2-ethoxy-benzoic acid-(2-piperidino-ethylamide) [ No CAS ]
  • 3
  • [ 27578-60-5 ]
  • [ 33045-53-3 ]
  • [ 102535-21-7 ]
  • 4
  • [ 27578-60-5 ]
  • [ 6492-86-0 ]
  • 6-Amino-2-(2-piperidin-1-yl-ethyl)-benzo[de]isoquinoline-1,3-dione [ No CAS ]
  • 5
  • [ 27578-60-5 ]
  • [ 27018-76-4 ]
  • 1-benzyl-1<i>H</i>-indole-3-carboxylic acid (2-piperidin-1-yl-ethyl)-amide [ No CAS ]
  • 6
  • [ 27578-60-5 ]
  • [ 5147-80-8 ]
  • [(2-piperidinoethylamino)(3-piperidinopropylamino)methylene]malononitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
45% Example 1 [(2-Piperidinoethylamino)(3-piperidinopropylamino) methylene]malononitrile (Compound 1) <strong>[5147-80-8][Bis(methylthio)methylene]malononitrile</strong> (300 mg, 1.76 mmol) was dissolved in THF (4 mL), and a solution obtained by dissolving 3-piperidinopropylamine (251 mg, 1.76 mmol) in THF (1 mL) was added thereto. After stirring the mixture at room temperature for 1.5 hours, a solution obtained by dissolving 1-(2-aminoethyl) piperidine (226 mg, 1.76 mmol) in THF (1 mL) was added thereto, followed by stirring at room temperature for 1.5 hours, and further stirring at 30C for 5 hours. After cooling, the resulting mixture was added with water, and the pH of the mixture was adjusted to 4 with 2 mol/L hydrochloric acid. Then, the pH of the mixture was adjusted to 9 with a saturated aqueous sodium hydrogen carbonate solution, and the precipitated solid was obtained by filtration. The obtained solid was washed with water, triturated with diisopropyl ether and recrystallized from n-hexane/ethyl acetate, to obtain the titled compound (273 mg, 45%) as a white solid.
  • 7
  • [ 27578-60-5 ]
  • [ 5147-80-8 ]
  • [(2-piperidinoethylamino)(4-piperidinopiperidino)methylene]malononitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
88% Example 143 [(2-Piperidinoethylamino)(4-piperidinopiperidino) methylene]malononitrile (Compound 143) <strong>[5147-80-8][Bis(methylthio)methylene]malononitrile</strong> (242 mg, 1.42 mmol) was dissolved in ethanol (2 mL) and the solution was added with a solution of 4-piperidinopiperidine (251 mg, 1.49 mmol) in ethanol (3 mL), followed by stirring at room temperature for 0.5 hour. The mixture was added with 1-(2-aminoethyl)piperidine (0.319 mL, 2.24 mmol) and stirred at 70C for 6 hours. Further, the mixture was added with 1-(2-aminoethyl) piperidine (0.213 mL, 1.49 mmol) and stirred at 70C for 2 hours. After cooling, the reaction mixture was added with saturated brine and extracted with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate and the solvent was evaporated under reduced pressure. The residue was purified by NH silica gel column chromatography (n-hexane/ethyl acetate (1:1)) to obtain the titled compound (465 mg, 88%) as a yellow oily substance. 1H NMR (CDCl3, δppm): 1.38-1.69 (m, 13H), 1.94 (d, J=11.2Hz, 2H), 2.34-2.57 (m, 12H), 3.08 (t, J = 12.9 Hz, 2H), 3.31-3.38 (m, 2H), 3.88 (d, J = 12.9 Hz, 2H), 5.97 (br s, 1H). APCIMS m/z: [M+H]+371. Melting point: 198-200C.
  • 8
  • [ 27578-60-5 ]
  • [ 58656-98-7 ]
  • [ 733785-78-9 ]
YieldReaction ConditionsOperation in experiment
64% at 120℃; Step 1: tert-Butyl 4- (2- (piperidin-1-yl) ethylamino) benzoate (187) [0348] tert-Butyl 4-FLUOROBENZOATE 185 (0.502g, 2.55 MMOL) and 24PIPERIDIN-1-YL) ETHANAMINE 186 (1.46 mL, 10.21 MMOL) were stirred neat at 120C overnight then diluted with ethyl acetate, washed with saturated aqueous sodium bicarbonate (LX), brine (LX), dried over magnesium sulfate and evaporated to give 187 (0.501g, 64%). H NMR: (DMSO) 6 (ppm): 400 MHz, (DMSO) d (ppm): 7.59 (d, J= 8.8 Hz, 2H), 6.55 (d, J= 8.8 Hz, 2H), 6.24 (t, J= 5.1 Hz, 1H), 4.11 (m, 2H), 3.21 to 3.13 (m, 6H), 2.44 (t, J= 7.1 Hz, 2H), 2.37 (m, 2H), 1.49 (s, 9H), 1.47 to 1.38 (m, 2H). MS: 304.22 (CALC), 249.1 (M-T8U).
  • 9
  • [ 27578-60-5 ]
  • [ 207399-07-3 ]
  • [ 1255954-14-3 ]
  • 10
  • [ 27578-60-5 ]
  • [ 171243-30-4 ]
  • [ 1415400-66-6 ]
YieldReaction ConditionsOperation in experiment
65% In dichloromethane; at 20℃; for 0.5h; General procedure: To a solution of benzoyl chloride (1 mmol) in dry dichloromethane (10 ml) was added amine (1 mmol), and the mixture was stirred for 0.5 h at room temperature. After solvent evaporation, the crude product was purified by column chromatography on silica (CHCl3:CH3CH2OH = 9:1) resulting in yellow thick oil and crystallized from the dichloromethane-petroleum ether mixture.
  • 11
  • [ 27578-60-5 ]
  • copper(II) nitrate trihydrate [ No CAS ]
  • [ 32596-43-3 ]
  • C22H33ClCu2N5O5(1+)*NO3(1-)*H2O [ No CAS ]
  • 12
  • [ 27578-60-5 ]
  • [ 23351-91-9 ]
  • 5-bromo-N1,N3-bis[2-(piperidin-1-yl)ethyl]benzene-1,3-dicarboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
89% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide; at 20℃; for 16h; To a solution of <strong>[23351-91-9]5-bromoisophthalic acid</strong> 1(200 mg, 0.82 mmol) and 1-piperidineethanamine (240 mL, 1.17mmol) in DMF (2.5 mL) was added EDC*HCl (330 mg, 1.73 mmol) and HOBt-H2O (25.2 mg, 0.165 mmol). The reaction mixture was stirred for 16 h at room temperature. 10 mL of saturated NaHCO3 solution was added. The aqueous layer was extracted with DCM(3 10 mL). The combined organic layer was dried over MgSO4 and evaporated. The residue was purified by flash chromatography(DCM/MeOH(NH3), 10:0 to 9.7:0.3 (v/v)). The title compound 14(340 mg, 0.73 mmol, 89percent) was obtained as a white solid. Mp:127.3 C. 1H NMR (300 MHz), d (ppm, CDCl3): 8.23 (t, J = 1.5 Hz,1H); 8.04 (d, J = 1.5 Hz, 2H); 7.46 (t, J = 4.7 Hz, 2H); 3.48 (td, J =5.9 Hz, J = 5.5 Hz, 4H); 2.50 (t, J = 6.1 Hz, 4H); 2.38 (m, 8H); 1.54(m, 8H); 1.40 (m, 4H). 13C NMR (75 MHz), d (ppm, CDCl3): 165.3;136.3; 133.2; 123.7; 123.0; 57.4; 54.3; 36.6; 25.7; 24.2. LC?MS(ESI) m/z Calculated: 465.2?467.2, Found: 465.0?466.9, 233.1?234.0 [(M+2H)/2]+.
 

Historical Records

Technical Information

Categories